Wyeth osteoporosis drug gets 3d ‘approval’ letter (Philly.com)
Wyeth Pharmaceuticals, Collegeville, announced today that it received its third “approvable” letter from the FDA for a drug being developed for the treatment of postmenopausal osteoporosis.